Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-03-28

FDA Approved: RIFAMPIN — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved an Original Application (ANDA) for rifampin submitted by Chartwell RX, LLC. This marks approval of a generic rifampin product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RIFAMPIN (RIFAMPIN)

Snippet

ORIG AP for RIFAMPIN (RIFAMPIN)